Human papillomavirus vaccine efficacy in the prevention of anogenital warts: systematic review and meta-analysis.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsTejada, Romina A
Vargas, Kris G
Benítes-Zapata, Vicente A.
Hernandez, Adrian V.
MetadataShow full item record
CitationHuman papillomavirus vaccine efficacy in the prevention of anogenital warts: systematic review and meta-analysis., 59 (1):84-94 Salud Publica Mex
PublisherInstituto Nacional de Salud Pública
JournalSalud publica de Mexico
AbstractObjective: To review evidence on the efficacy of HPV vaccines in the prevention of non-cancer lesions (anogenital warts [AGW], recurrent laryngeal papillomatosis and oral papillomatosis). Materials and methods: We conducted a systematic review of randomized trials. We performed random effect models and effects were reported as relative risks (RR) and their confidence intervals (95%CI) following both intention to treat (ITT) and per protocol (PP) analyses. Results: We included six studies (n=27 078). One study was rated as high risk of bias. One study could not be included in the meta-analysis because it provided combined results. We found that quadrivalent vaccine reduced the risk of AGW by 62% (RR: 0.38, 95%CI:0.32-0.45, I2:0%) in the ITT analysis and by 95% (RR: 0.05, 95%CI:0.01-0.25, I2:66%) in the PP analysis. Subgroup analyses of studies in women or with low-risk of bias provided similar results. Conclusion: HPV quadrivalent vaccine is efficacious in preventing AGW in men and women.
HPV quadrivalent vaccine is efficacious in preventing AGW in men and women.
The following license files are associated with this item:
- Vaccines for preventing HPV-related anogenital infection and neoplasia.
- Authors: Ferris DG
- Issue date: 2006 Mar
- The early benefits of human papillomavirus vaccination on cervical dysplasia and anogenital warts.
- Authors: Smith LM, Strumpf EC, Kaufman JS, Lofters A, Schwandt M, Lévesque LE
- Issue date: 2015 May
- Anogenital warts and other HPV-associated anogenital lesions in the HIV-positive patient: a systematic review and meta-analysis of the efficacy and safety of interventions assessed in controlled clinical trials.
- Authors: Werner RN, Westfechtel L, Dressler C, Nast A
- Issue date: 2017 Dec
- Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimates.
- Authors: Ong KJ, Checchi M, Burns L, Pavitt C, Postma MJ, Jit M
- Issue date: 2019 Feb
- Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a review of its use in the prevention of premalignant genital lesions, genital cancer and genital warts in women.
- Authors: McCormack PL, Joura EA
- Issue date: 2010 Dec 24